2022 annual financial data
Anika Therapeutics 2022 Operating margin
Direct answer
Operating margin was -12.42%.
Operating income was -19,400,000 USD and net income was -14,859,000 USD.
Operating cash flow was 4,409,000 USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 156,236,000 USD
- Operating income
- -19,400,000 USD
- Net income
- -14,859,000 USD
- Operating cash flow
- 4,409,000 USD